Recent studies have also highlighted that DPP-4 inhibition attenuates obesity-related inflammation, atherosclerosis, and insulin resistance by regulating M1/M2 macrophage polarization [33, 34]. The gene discussed is DPP4; the disease is obesity due to melanocortin 4 receptor deficiency.